Press Releases

Blood Glucose Monitoring Systems Market at US$ 15.4 Bn in 2018 and is projected to expand at a CAGR of 5.5% from 2019 to 2030

According to the National Institute of Diabetes and Digestive and Kidney Diseases, in the U.S., 23.1 million patients were diagnosed with diabetes at a cost of more than US$ 245 Mn per year

High Prevalence of Diabetes Mellitus and Advancements in Technology to Augment Market

Within the blood glucose monitoring systems market, at present, companies are increasingly focusing on the development of advanced next-generation glucose monitoring systems to gain an edge in the current market landscape. Non-invasive glucose monitoring techniques have gained noteworthy popularity over the past couple of decades, and the trend is set to continue to gain momentum during the forecast period. Technological advancements continue to drive innovations in the blood glucose monitoring systems market and improve diagnostic techniques and equipment. Research and development activities continue to explore and discover new non-invasive glucose monitoring techniques.

Get the sample copy of report@ https://qyresearchmedical.com/sample/111666

Over the past few years, research and development activities have put forward infrared spectroscopy– a novel technology that is expected to offer tremendous scope in the blood glucose monitoring systems market. Rapid advancements in technology and improvement in the reliability and calibrating methods of non-invasive devices are some of the factors that are expected to augment the growth of the market for blood glucose monitoring systems in the coming years. The high prevalence of diabetes worldwide is one of the major causes of morbidity and mortality in most regions around the world. Surge in the aging population worldwide, unhealthy dietary patterns, an increase in the number of individuals leading a sedentary lifestyle and obesity are expected to increase the prevalence of diabetes mellitus in the coming years which in turn is expected to propel the demand for advanced blood glucose monitoring systems. At the back of these factors coupled with favorable government policies, the global blood glucose monitoring systems market is expected to reach ~US$ 25 Bn by the end of 2027.

High Adoption of Non-invasive Monitoring Leveraging Optical Techniques Likely to Propel Market Growth

Due to the growing prevalence of diabetes mellitus across the world, the pursuit of efficient blood glucose monitoring systems has gained considerable pace over the past few years– a trend that is likely to continue during the forecast period. Governments of both the developing as well as developed nations of the world are increasingly encouraging research and development activities that aim to minimize health complications caused by blood glucose levels. Non-invasive blood glucose monitoring systems have gained considerable traction in recent years of which, vibrational spectroscopy-based techniques of the skin have emerged as promising candidates.

Get a glimpse of the in-depth analysis through our Report Brochure

At present, researchers are also increasingly investigating the potential benefits of deploying devices based on photoplethysmography, wherein wavelengths in near-infrared range are being considered for their exceptional capabilities of offering dependable blood glucose monitoring predictions. Optical glucose sensing is projected to remain one of the most critical types of treatment within the blood glucose monitoring systems market during the forecast period. Steady progress in biosensor technologies and growing emphasis on non-invasive blood glucose monitoring is expected to further accelerate the adoption of optical techniques in the blood glucose monitoring systems market. Advancements in technology have paved the way for a host of blood glucose monitoring systems and techniques, including Raman spectroscopy, fluorescence spectroscopy, absorption spectroscopy, photoacoustic spectroscopy, and ocular spectroscopy, among others.

View full report@ https://qyresearchmedical.com/report/blood-glucose-monitoring-systems-market-product-self-monitoring-blood-glucose-systems-blood-glucose-meters-testing-strips-lancing-devices-and-lancets-and-continuous-glucose-monitoring-systems-sensors-transm-019-2030/111666

The future of the blood glucose monitoring systems market is expected to hinge on the strides taken by nanotechnology and significant progress in biomaterials. Companies operating in the current market landscape are expected to develop glucose biosensors that are predominantly based on polymer nanocomposites, carbon nanotubes, and grapheme.

Market Participants Develop Smart Blood Glucose Monitoring Systems to Gain Advantage

With technology progressing at a rapid pace, several companies are inclined toward the development of advanced blood glucose monitoring systems based on these technologies. Participants in the blood glucose monitoring systems market are expected to collaborate with pharmaceutical companies to launch reliable next-generation glucose monitoring systems. For instance, in January 2019, Eris Lifesciences and India Medtronic Pvt. Ltd announced that the two companies are collaborating to formulate efficient diabetes monitoring programs and initiatives in India. Both companies will leverage expertise from one another to develop advanced blood glucose monitoring systems. Both the companies announced the launch of the smart continuous blood glucose monitoring system, which can be connected with smartphones to gain real-time data, including glucose levels without excessive hardware requirements. Moreover, established brands are also launching new products and expanding their product range to improve their market share. For instance, in January 2018, Abbott announced the launch of the FreeSbtyle Libre System, an advanced continuous glucose monitoring system.

Analysts’ Viewpoint

The global blood glucose monitoring systems market is expected to grow at a steady CAGR of ~5.5% during the forecast period. Some of the leading factors that will contribute to market growth include rapid developments in optical and non-invasive monitoring techniques, high prevalence of diabetes mellitus worldwide, rise in the geriatric population, and policies by government bodies worldwide that encourage the development of reliable, accurate, and efficient blood glucose monitoring systems. Companies should focus on expanding their product portfolio, improve the accuracy of their products, and continue to invest in new technologies to improve their market share in the current market landscape.

Blood Glucose Monitoring Systems Market: Overview

According to Transparency Market Research’s latest research report on the global blood glucose monitoring systems market for the historical period (2017–2018) and the forecast period (2019–2027), rise in prevalence of diabetes is anticipated to drive the global blood glucose monitoring systems market in the near future

According to the report, the global blood glucose monitoring systems market was valued at US$ 15.4 Bn in 2018 and is projected to expand at a CAGR of 5.5% from 2019 to 2027

Rise in Prevalence of Diabetes: A Key Driver for Blood Glucose Monitoring Systems Market

Complex interaction between genes and environmental factors are responsible for causing type 1 diabetes. Obesity, dietary habits, family history of diabetes, and physical inactivity are the major risk factors for type 2 diabetes.

Prevalence of diabetes is rising due to change in lifestyle, environmental factors, and genetic mutation. Moreover, obesity is a key risk factor responsible for causing diabetes.

According to the American Diabetes Association, an estimated 30.3 million people in the U.S. had diabetes in 2015, among these 1.25 million were children

Purchase Complete Report Now@ https://qyresearchmedical.com/report/checkout/111666/2900

According to the World Health Organization, an estimated 1.6 million deaths occurred due to diabetes in 2016

A report published by the World Health Organization stated that an estimated 422 million adults were living with diabetes globally in 2014 and the prevalence is rising in the adult population

According to the British Diabetic Association operating as Diabetes UK, in the U.K., 3.8 million people were diagnosed with diabetes in 2019

According to Diabetes U.K., 382 million adults across the globe aged between 20 and 79 had diabetes in 2012. This number is expected to reach 592 million by 2035. An estimated 175 million people are undiagnosed with type 2 diabetes.

Prevalence of diabetes is variable and is expected to increase in the near future

Increase in Awareness about Diabetes: Blood Glucose Monitoring Systems Market

Diabetes is a leading cause of death across the world. Prevalence of diabetes is increasing in the adult as well as pediatric population.

In November 2018, the American Diabetes Association entered into a partnership with American Heart Association to increase awareness about cardiovascular diseases caused due to type 2 diabetes

Diabetes is a leading cause of deaths in India. The Ministry of Health and Family Welfare (MoHFW) launched mDiabetes, a mobile health initiative for prevention and care of diabetes, in collaboration with the WHO Country Office for India and other partners.

The Division of Diabetes and Translation, a department of CDC, supports activities and programs to prevent type 2 diabetes and improve patient health outcomes

In March 2015, the NHS and Public Health England launched a National NHS Diabetes Prevention Program. Prevalence of type 2 diabetes reduced in the U.K. due to this program.

The National Programme for Prevention and Control of Cancers, Diabetes, Cardiovascular Diseases and Stroke is arranged by National Health Mission. The aim of the program is to strengthen the infrastructure, early diagnostics by primary healthcare system, and health prevention from diabetes.

In November 2018, Onduo conducted a virtual diabetes program for people living with type 2 diabetes in Georgia

High Cost of Blood Glucose Monitoring Systems to Hamper Global Market

Cost is a major factor influencing the selection of treatment. The cost of traditional methods for diabetes management is less than that for digital diabetes management.

The cost of digital diabetes management devices is a barrier in the treatment of type 1 diabetes in adults

According to an article published in AJMC, the estimated cost of insulin infusion pump per person is about US$ 4,500, with additional cost for supplies exceeding US$ 1,500 per year

Hence, the high cost of the blood glucose monitoring systems can restrain the market

Patient and Provider Burden to Restrain Global Blood Glucose Monitoring Systems Market

Diabetes is among the leading causes of death across the globe. According to the World Health Organization, prevalence of diabetes is increasing in low and middle income countries. The prevalence of diabetes increased from 4.7 % in 1980 to 8.5% in 2014.

According to the Centers for Diseases Control and Prevention, an estimated 30.3 million people in the U.S. had diabetes in 2017

According to the National Institute of Diabetes and Digestive and Kidney Diseases, in the U.S., 23.1 million patients were diagnosed with diabetes at a cost of more than US$ 245 Mn per year

Lack of providers affects people with diabetes in rural areas

Rise in prevalence of diabetes is increasing the demand and supply gap for healthcare providers

Blood Glucose Monitoring Systems Market: Competition Landscape

This report profiles major players operating in the global blood glucose monitoring systems market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments

The global blood glucose monitoring systems market is moderately fragmented, with the presence of a few large players in the international market and numerous small players in regional markets. The top four to five players hold major share of the global blood glucose monitoring systems market.

Prominent players operating in the global blood glucose monitoring systems market  include

  • Abbott
  • Medtronic
  • Hoffmann-La Roche Ltd
  • B.Braun Melsungen AG
  • AgaMatrix
  • Sanofi-aventis
  • SD Biosensor, INC
  • LifeScan
  • Ascensia Diabetes Care
  • Prodigy Diabetes Care, LLC
  • Nipro
  • Dexcom, Inc.
  • Ypsomed AG
  • Senseonics
  • ACON Laboratories, Inc.

The report on the global blood glucose monitoring systems market discusses individual strategies, followed by company profiles of manufacturers of blood glucose monitoring systems. The ‘competitive landscape’ section has been included in the blood glucose monitoring systems market report to provide readers with a dashboard view and a company market share analysis of key players operating in the global blood glucose monitoring systems market.

Key Questions Answered in Blood Glucose Monitoring Systems Market Report

  • What is the scope of growth of devices and its companies in the blood glucose monitoring systems market and its application sector?
  • What will be the Y-o-Y growth of the global blood glucose monitoring systems market between 2019 and 2027?
  • What is the influence of changing trends in technologies on the global blood glucose monitoring systems market?
  • Will Americas continue to be the most profitable regional market for global primary immunodeficiency therapy providers?
  • Which factors will impede the growth of the global blood glucose monitoring systems market during the forecast period?
  • Which are the leading companies in the global blood glucose monitoring systems market?

Blood Glucose Monitoring Systems Market – Segmentation

Product

  • Self-monitoring Blood Glucose Systems
  • Blood Glucose Meters
  • Testing Strips
  • Lancing Devices
  • Lancets
  • Continuous Glucose Monitoring Systems
  • Sensors
  • Transmitters
  • Receivers

Application

  • Type 1 Diabetes
  • Type 2 Diabetes
  • Gestational Diabetes

Testing Site

  • Fingertip Testing
  • Alternate Site Testing

Patient Care Setting

  • Self/Home Care
  • Hospitals
  • Clinics

Region

  • Americas
  • Europe
  • Asia Pacific
  • Middle East & Africa

TABLE OF CONTENT

1. Preface

1.1. Market Definition and Scope

1.2. Market Segmentation

1.3. Key Research Objectives

1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Blood Glucose Monitoring Systems Market

4. Market Overview

4.1. Introduction

4.1.1. Type Definition

4.1.2. Industry Evolution / Developments

4.2. Overview

4.3. Market Dynamics

4.3.1. Drivers

4.3.2. Restraints

4.3.3. Opportunities

4.4. Global Blood Glucose Monitoring Systems Market  Analysis and Forecast, 2017–2027

4.4.1. Market Revenue Projections (US$ Mn)

4.5. Porter’s Five Force Analysis

5. Key Insights

5.1. Price Analysis

5.1.1. Average Price per Meter and Strip

5.1.2. Reimbursement Price by Region

5.2. Disease Prevalence & Incidence Rate Globally with Key Countries

5.3. Key Vendor and Distributor Analysis

5.4. Reimbursement Scenario by Region/Globally

5.5. Supply Chain Analysis, by Country (Market Structure)

5.6. Marketing Strategies and Promotional Activities

6. Global Blood Glucose Monitoring Systems Market  Analysis and Forecast, by Product Type

6.1. Introduction & Definition

6.2. Key Findings / Developments

6.3. Market Value Forecast, by Product Type, 2017–2027

6.3.1. Self-monitoring Blood Glucose Systems

6.3.1.1. Blood Glucose Meters

6.3.1.2. Testing Strips

6.3.1.3. Lancing Devices

6.3.1.4. Lancets

6.3.2. Continuous Glucose Monitoring Systems

6.3.2.1. Sensors

6.3.2.2. Transmitters

6.3.2.3. Receivers

6.4. Market Attractiveness, by Product Type

7. Global Blood Glucose Monitoring Systems Market  Analysis and Forecast, by Application

7.1. Introduction & Definition

7.2. Key Findings / Developments

7.3. Market Value Forecast, by Application, 2017–2027

7.3.1. Type 1 Diabetes

7.3.2. Type 2 Diabetes

7.3.3. Gestational Diabetes

7.4. Market Attractiveness, by Application

8. Global Blood Glucose Monitoring Systems Market  Analysis and Forecast, by Testing Site

8.1. Introduction & Definition

8.2. Key Findings / Developments

8.3. Market Value Forecast, by Testing Site, 2017–2027

8.3.1. Fingertip Testing

8.3.2. Alternate Site Testing

8.4. Market Attractiveness, by Testing Site

9. Global Blood Glucose Monitoring Systems Market  Analysis and Forecast, by Patient Care Settings

……..

Purchase Complete Report Now@ https://qyresearchmedical.com/report/checkout/111666/2900

You can place an order or ask any questions, please feel free to contact sales@qyresearchmedical.com | +1 9197 992 333

About Us

QYResearch Medical, focuses on custom research, management consulting, IPO consulting, industry chain research, and data base & seminar services. The company owns large basic databases (such as National Bureau of Statistics Database, Customs Import and Export Database, Industry Association Database, etc.), expert resources (including industry experts who own more than 10 years experiences on marketing or R&D in industries of healthcare services, medical technology & devices, etc.), professional survey team (the team members obtained more than 3 years market survey experience and more than 2 years deep expert interview experience), and excellent data analysis team (SPSS statistics and PPT graphics process team).

QYResearch Medical has more than 4000 global well-known customers, covering more than 30 industries including pharmaceuticals, medical technology & devices, healthcare services etc. Company services cover one-stop solution as Data-Analysis-Suggestion-Consulting Implementation. Research regions cover China, US, EU, Asia, Middle East and Africa, South America, Australia, and other regions in the world.

For Latest Update Follow Us:

https://www.linkedin.com/company/qyresearch-medical/

https://www.facebook.com/QYResearch-Medical-108186514228917/

https://twitter.com/qyresearchmedi

Show More

Related Articles

Back to top button